Data updated: Mar 10, 2026
CLOBAZAM
CLOBAZAM
Approved 2018-10-22
18
Indications
--
Phase 3 Trials
7
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2018-10-22
- Routes
- ORAL
- Dosage Forms
- TABLET, SUSPENSION
Companies
NOVITIUM PHARMA VISTAPHARM LLC ACCORD HLTHCARE Aurobindo Pharma HETERO LABS LTD III Lupin TARO ALKEM LABS LTD BIONPHARMA PHARMOBEDIENT CHARTWELL RX AMNEAL PHARMS CO Hikma UPSHER SMITH LABS CHARTWELL MOLECULAR MSN PIRAMAL Apotex AMNEAL Teva ZYDUS PHARMS MICRO LABS
Active Ingredient: CLOBAZAM
Website: ↗
CLOBAZAM Approval History
Loading approval history...
What CLOBAZAM Treats
18 FDA approvalsOriginally approved for its first indication in 2018 . Covers 18 distinct patient populations.
- Other (18)
Other
(18 approvals)- • Approved indication (Oct 2018)
- • Approved indication (Dec 2018)
- • Approved indication (Dec 2018)
- • Approved indication (Jan 2019)
- • Approved indication (Apr 2019)
- • Approved indication (May 2019)
- • Approved indication (Jul 2019)
- • Approved indication (Sep 2019)
- • Approved indication (Oct 2019)
- • Approved indication (Jan 2020)
- • Approved indication (Feb 2020)
- • Approved indication (Apr 2020)
- • Approved indication (Jun 2020)
- • Approved indication (Dec 2020)
- • Approved indication (May 2021)
- • Approved indication (May 2021)
- • Approved indication (Mar 2022)
- • Approved indication (Sep 2022)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CLOBAZAM FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.